Last reviewed · How we verify
NCT04597333
Labor Induction After Failed Induction With Dinoprostone.
NA trial testing Dinoprostone in Induction of Labor Affected Fetus / Newborn in 144 participants. Completed in 31 December 2021.
30 November 2021
Quick facts
| Lead sponsor | Rambam Health Care Campus |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 144 |
| Start date | 15 October 2020 |
| Primary completion | 30 November 2021 |
| Estimated completion | 31 December 2021 |
| Sites | 1 location across Israel |
Drugs / interventions tested
- Dinoprostone (DINOPROSTONE) — full drug profile →
- Cervical ripening balloon.
Conditions studied
- Induction of Labor Affected Fetus / Newborn — all drugs for Induction of Labor Affected Fetus / Newborn →
Sponsor
Rambam Health Care Campus — full company profile →
Who can join
Adults 18 to 45, female only, with Induction of Labor Affected Fetus / Newborn. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Women after induction of labor with a dinoprostone insert will be evaluated after 24 hours from the beginning of labor induction. Women with a BISHOP score of less than 5 will be randomized to 1 of 2 groups. Induction with a cervical ripening balloon versus induction with a 2nd dinoprostone insert.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04597333
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Dinoprostone
Trials testing the same drug.
- NCT04079140 — Vaginal Dinoprostone Administration Prior to Intrauterine Device Insertion · Phase 4 · completed
- NCT04080336 — Comparison of Vaginal Misoprostol and Dinoprostone Prior to Copper Intrauterine Device Insertion in Nulliparous Women · Phase 4 · completed
- NCT04046302 — Vaginal Dinoprostone Administration Prior to an Intrauterine Device Insertion in Multiparous Women. · Phase 4 · completed
- NCT04044079 — Vaginal Dinoprostone Versus Vaginal Misoprostol Prior to Diagnostic Office Hysteroscopy in Postmenopausal Patients · Phase 4 · completed
- NCT04045548 — Vaginal Dinoprostone Administration Prior to Insertion Levonorgestrel-releasing Intrauterine System in Women With no Pre · Phase 4 · completed
Other recruiting trials for Induction of Labor Affected Fetus / Newborn
Currently open trials in the same condition.
- NCT06375746 — The Impact of a Customized Informative Video Prior to Induction of Labor on Anxiety Relieve. · NA · recruiting
- NCT06325007 — Castor Oil Ingestion and Balloon Catheter for Labor Induction in Nulliparous · NA · recruiting
- NCT06187779 — Induction ATAD Catheter and Lower Segment Thickness · NA · active not recruiting
- NCT05759988 — Cervical Ripening as an Outpatient Method Using the Foley (COMFORT) · NA · recruiting
Other Rambam Health Care Campus trials
Trials by the same sponsor.
- NCT07384013 — Study Protocol: Impact of Metamizole (Optalgin®) on Anti-Xa Concentrations in Oncology Patients Receiving DOACs · NA · recruiting
- NCT06688253 — Intravenous Human IgG1 Fc Fragment (Efgartigimod) in Myasthenic Crisis · Phase 4 · not yet recruiting
- NCT06235749 — Administration Of Calcium Gluconate for The Reduction of Blood Loss During Elective Cesarean Delivery · NA · recruiting
- NCT06622902 — Influence of Flow Rate Change on CO2 Levels During High Flow Nasal Ventilation (HFNV) in Preterm Infants. · NA · recruiting
- NCT05922111 — Cervical Ripening Balloon for 12 Hours vs. 1 Hour. · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04597333 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Rambam Health Care Campus
- Last refreshed: 20 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04597333.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing